| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/03/2007 | WO2007030697A3 Modulation of neurogenesis by hdac inhibition |
| 05/03/2007 | WO2007025988A3 Liquid formulations of pegylated growth hormone |
| 05/03/2007 | WO2007022219A3 Dental composition comprising enzyme |
| 05/03/2007 | WO2007020405A3 Integrin i-domain binding peptides |
| 05/03/2007 | WO2007019427A3 Methods and compositions for preserving the viability of photoreceptor cells |
| 05/03/2007 | WO2007015841A3 A method for treating preeclampsia |
| 05/03/2007 | WO2007002886A3 Compositions and methods for less immunogenic pr0tein-lip1d complexes |
| 05/03/2007 | WO2006133403A3 Inhibitors of serine protease activity and their use in methods and compositions for treatment of graft rejection and promotion of graft survival |
| 05/03/2007 | WO2006133160A3 Compositions and methods for lipo modeling |
| 05/03/2007 | WO2006133147A3 Organic compounds |
| 05/03/2007 | WO2006121362A3 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
| 05/03/2007 | WO2006109192A8 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith |
| 05/03/2007 | WO2006108556A3 Pharmaceutical aerosol composition |
| 05/03/2007 | WO2006107990A3 Improving protein n-glycosylation of eukaryotic cells using dolichol-linked oligosaccharide synthesis pathway, other n-gylosylation-increasing methods, and engineered hosts expressing products with increased n-glycosylation |
| 05/03/2007 | WO2006103274A8 Age inhibitors |
| 05/03/2007 | WO2006081516A3 USE OF BAFF TO TREAT Th2-MEDIATED CONDITIONS |
| 05/03/2007 | WO2006067792A3 Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease |
| 05/03/2007 | WO2006041939A3 Use of aromatase inhibitors for endometrial thinning in preparation for surgical procedures on the endometrial cavity and uterus |
| 05/03/2007 | WO2005113596A3 Cell surface receptor isoforms and methods of identifying and using the same |
| 05/03/2007 | WO2005092069A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 05/03/2007 | WO2005037989A3 Binding domain-immunoglobulin fusion proteins |
| 05/03/2007 | WO2005007073A3 Ex vivo progenitor and stem cell expansion for use in the treatment of disease of endodermally-derived organs |
| 05/03/2007 | WO2004111198A3 Modified human acid sphingomyelinase having increased activity, and methods for making the same |
| 05/03/2007 | WO2004092350A3 G-protein coupled receptors |
| 05/03/2007 | WO2004084820A3 Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients |
| 05/03/2007 | WO2004018643A3 Method for regulating dopamine producing cells |
| 05/03/2007 | WO2003052049A3 Molecules for disease detection and treatment |
| 05/03/2007 | WO2002081649A3 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF |
| 05/03/2007 | US20070101451 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 05/03/2007 | US20070101450 DNA that encodes a protein having high-affinity choline transporter activity |
| 05/03/2007 | US20070101448 Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use |
| 05/03/2007 | US20070101447 Diagnostic tests for the detection of motor neuropathy |
| 05/03/2007 | US20070101446 Antibodies against epitopes with homology to self antigens, methods of preparation |
| 05/03/2007 | US20070100133 Erythropoietic compounds |
| 05/03/2007 | US20070100015 Gels for encapsulation of biological meterials |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099866 Stable pharmaceutical compositions of 5,10-methylene tetrahydrofolate |
| 05/03/2007 | US20070099864 Use of o-atp for the treatment of diseases involving angiogenesis |
| 05/03/2007 | US20070099857 Methods and means for inhibiting fever |
| 05/03/2007 | US20070099848 Rapamycin carbohydrate derivatives |
| 05/03/2007 | US20070099846 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic |
| 05/03/2007 | US20070099845 N-Acetyl L-Cysteine and L-Cysteine Choline Esters, and (R)-[2-(2,2-Dimethyl-thiazolidine-4-carbonyloxy)-ethyl]trimethyl-ammonium chloride, for example; compounds may be used to inhibit oxidative stress-induced cell injury or death both in vivo and ex vivo |
| 05/03/2007 | US20070099844 Novel methods for the treatment of cancer |
| 05/03/2007 | US20070099843 Nutritional supplement for the enhancement of the health of the liver |
| 05/03/2007 | US20070099842 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
| 05/03/2007 | US20070099841 Prodrugs of T3 and T4 with enhanced bioavailability |
| 05/03/2007 | US20070099840 Hydrogel compositions |
| 05/03/2007 | US20070099839 Inhibitors of cell migration |
| 05/03/2007 | US20070099838 Plant-derived peptides harboring water-cleaning and antimicrobial activities |
| 05/03/2007 | US20070099837 Increasing cartilage deposition by administering a fibroblast growth factor homolog polypeptide to a fibrocartilage, hyaline, or elastic cartilage injury in patient; osteoarthritis treatment |
| 05/03/2007 | US20070099836 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 05/03/2007 | US20070099835 Sustained release GLP-1 receptor modulators |
| 05/03/2007 | US20070099834 Compositions and methods related to anti-FGF agents |
| 05/03/2007 | US20070099833 Albumin fusion proteins |
| 05/03/2007 | US20070099832 Combination Therapy with p38 MAP Kinase Inhibitors and their Pharmaceutical Compositions |
| 05/03/2007 | US20070099831 Parathyroid hormone analogues and methods of use |
| 05/03/2007 | US20070099830 Sirt4 activities |
| 05/03/2007 | US20070099829 Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts |
| 05/03/2007 | US20070099828 Biomarkers for the efficacy of calcitonin and parathyroid hormone treatment |
| 05/03/2007 | US20070099827 Sialogogue, oral composition and fool product containing the same |
| 05/03/2007 | US20070099826 Treatment of diseases associated with the egr-1 enhancer element |
| 05/03/2007 | US20070099825 Hepatitis C virus inhibitors |
| 05/03/2007 | US20070099824 Treatments which Alleviate Functional Glycosylated Leptin Transport Factor, for Controlling Weight and Obesity |
| 05/03/2007 | US20070099823 Inhibitors of sporeforming pathogens and applications of the same |
| 05/03/2007 | US20070099822 Regulation of tissue mineralization and phosphate metabolism by asarm peptides |
| 05/03/2007 | US20070099821 method of activating insulin receptor substrate-2 to stimulate insulin production |
| 05/03/2007 | US20070099820 Polymer-drug conjugates |
| 05/03/2007 | US20070099819 Locally administering at the site of the tendon reconstructive surgery an effective amount of saratin, a polypeptide component of leech saliva and a collagen-dependent platelet adhesion inhibitors; antiscarring agents; prevention of biological adhesions and keloids |
| 05/03/2007 | US20070099275 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance |
| 05/03/2007 | US20070099271 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 05/03/2007 | US20070099270 Novel neurotrophic factors |
| 05/03/2007 | US20070099269 Cytokine zalpha11 ligand |
| 05/03/2007 | US20070099263 Materials and methods relating to g-protein coupled receptor oligomers |
| 05/03/2007 | US20070099255 Diagnostics and therapeutics for diseases associated with n-acetylated alpha-linked acidic dipeptidase 2(naaladase 2) |
| 05/03/2007 | US20070099230 Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecles, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor |
| 05/03/2007 | US20070099215 NOVEL Bak BINDING PROTEIN, DNA ENCODING THE PROTEIN, AND METHODS OF USE THEREOF |
| 05/03/2007 | US20070099199 Identifying modulators which interfere with complex formation between human papilloma viral protein E6 and membrane associated guanylate kinase-1 MAGI-1); antitumor agents |
| 05/03/2007 | US20070099181 isolation and characterization of new porcine circovirus (PCV) isolates from pigs displaying postweaning multisystemic wasting syndrome (PMWS). |
| 05/03/2007 | US20070099175 Modified fluorescent proteins |
| 05/03/2007 | US20070098808 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases arthritis, skin cancer diabetes, premenstrual syndrome and transdermal transport |
| 05/03/2007 | US20070098807 Matrices for drug delivery and methods for making and using the same |
| 05/03/2007 | US20070098802 Organic nanoparticles and associated methods |
| 05/03/2007 | US20070098793 Oxymorphone controlled release formulations |
| 05/03/2007 | US20070098792 Oxymorphone controlled release formulations |
| 05/03/2007 | US20070098790 Nutritional supplement for the enhancement of the health of the liver |
| 05/03/2007 | US20070098781 Modified release compositions for DPP-IV inhibitors |
| 05/03/2007 | US20070098776 HLA class I A2 tumor associated antigen peptides and vaccine compositions |
| 05/03/2007 | US20070098754 Method and article to restore function to GI or urinary tract of a patient |
| 05/03/2007 | US20070098747 Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
| 05/03/2007 | US20070098741 Vectors derived from antibodies for transferring substances into cells |
| 05/03/2007 | US20070098736 Injection vehicle for polymer-based formulations |
| 05/03/2007 | US20070098731 Treatment of infection due to clostridium difficile |
| 05/03/2007 | US20070098730 using a glycoconjugate comprising a dendrimeric or linear poly-Lysine enabling multiple epitopes to be covalently attached thereto; anticancer or antitumor agents |
| 05/03/2007 | US20070098729 Involves STEAP (six transmembrane epithelial antigen of the prostate); exposing cell to paclitaxel, androgen blocker, or immunomodudulator conjugated to antibody or fragment; drug delivery; diagnosis and therapy of prostate cancer, colon cancer, bladder cancer, ovarian cancer and pancreatic cancer; |
| 05/03/2007 | US20070098728 Novel compositions and methods in cancer |
| 05/03/2007 | US20070098725 Antibody against fragments of apo-lipoprotein B; ischemic cardiovascular diseases |
| 05/03/2007 | US20070098724 Methods of Treatment Using Vascular Occlusion in Combination with One or More Therapies |
| 05/03/2007 | US20070098722 Medicament comprising inhibitors of long pentraxin ptx3 |
| 05/03/2007 | US20070098721 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
| 05/03/2007 | US20070098720 Cd40-binding apc-activating molecules |